Ibrutinib: First Global Approval

Overview of attention for article published in Drugs, January 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 16 patents

Citations

dimensions_citation: 112 Dimensions

Readers on

mendeley: 105 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 16 patents that reference this research output.

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Grant US-10961251-B1

United States of America

Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor

Grant US-10828259-B2

United States of America

Crystalline forms of a brutons tyrosine kinase inhibitor

Grant US-10752634-B2

United States of America

Treatment method by combined use of MDM2 inhibitor and BTK inhibitor

Application US-10485794-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 12 additional patents.